IGF1 and neoplasm: have observed that the IGF1/IGF1R axis inhibition enhanced the efficacy of immunogenic chemotherapy, which correlated with an increase in tumor infiltrating effector T cells and a decrease in T-regs, in breast tumor mouse models (56, 57).